Also trades as: TLT.V (TSXV) · $vol 0M
TLTFF OTC
Theralase Technologies Inc.
1W: +1.2%
1M: -7.6%
3M: -35.3%
YTD: -5.0%
1Y: -8.2%
3Y: -21.7%
5Y: -30.4%
$0.13
+0.00 (+0.28%)
Weekly Expected Move ±5.1%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
-3.4% ▼
5Y CAGR: +1.4%
Gross Profit
$554K
-1.4% ▼
5Y CAGR: +55.6%
Operating Income
-$4M
+6.7% ▲
Net Income
-$4M
+6.9% ▲
EPS (Diluted)
$-0.02
+14.9% ▲
EBITDA
-$4M
+6.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $929K | $781K | $1M | $1M | $1M |
| YoY Growth | -3.6% | -16.0% | +45.9% | -6.0% | -3.4% |
| Cost of Revenue | $659K | $471K | $510K | $508K | $479K |
| Gross Profit | $270K | $310K | $628K | $562K | $554K |
| Gross Margin | 29.0% | 39.7% | 55.2% | 52.5% | 53.6% |
| R&D Expenses | $3M | $3M | $4M | $3M | $3M |
| SG&A Expenses | $2M | $2M | $2M | $2M | $2M |
| Operating Expenses | $6M | $5M | $6M | $5M | $5M |
| Operating Income | -$6M | -$5M | -$5M | -$5M | -$4M |
| Operating Margin | -602.0% | -581.8% | -459.5% | -429.2% | -415.0% |
| Interest Expense | $10K | $5K | $21K | $30K | $24K |
| Income Before Tax | -$6M | -$4M | -$5M | -$5M | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$6M | -$4M | -$5M | -$5M | -$4M |
| Net Margin | -602.6% | -565.1% | -459.8% | -427.1% | -411.8% |
| EPS (Diluted) | $-0.03 | $-0.02 | $-0.03 | $-0.02 | $-0.02 |
| EBITDA | -$5M | -$4M | -$5M | -$4M | -$4M |
| Shares Outstanding | 204M | 204M | 208M | 220M | 240M |